Mineralys Therapeutics (MLYS) Assets Average (2023 - 2026)

Quarterly results put Assets Average at $657.3 million for Q1 2026, up 134.41% from a year ago — trailing twelve months through Mar 2026 was $657.3 million (up 134.41% YoY), and the annual figure for FY2025 was $433.9 million, up 89.65%.

Mineralys Therapeutics has reported Assets Average over the past 4 years, most recently at $657.3 million for Q1 2026.

  • Assets Average reached $657.3 million in Q1 2026 per MLYS's latest filing, up from $630.9 million in the prior quarter.
  • Across five years, Assets Average topped out at $657.3 million in Q1 2026 and bottomed at $210.4 million in Q1 2023.
  • Median Assets Average over the past 4 years was $298.8 million (2023), compared with a mean of $354.1 million.
  • The largest annual shift saw Assets Average dropped 10.4% in 2024 before it soared 166.11% in 2025.
  • Over 4 years, Assets Average stood at $264.6 million in 2023, then dropped by 10.4% to $237.1 million in 2024, then skyrocketed by 166.11% to $630.9 million in 2025, then grew by 4.19% to $657.3 million in 2026.
  • Business Quant data shows Assets Average for MLYS at $657.3 million in Q1 2026, $630.9 million in Q4 2025, and $467.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - 13.04 Mn
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - 33.42 Mn
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn 1.72 Bn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - 331.70 Mn
5 Akari Therapeutics 605.66 Bn 605.66 Bn - 40.89 Mn
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 26.06 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 40.71 Bn
8 Evaxion A 65.12 Bn 65.10 Bn - 26.03 Mn
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 5.05 Bn
10 Mineralys Therapeutics 2.50 Bn 2.50 Bn - 657.33 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 657.33 Mn
Dec 31, 2025 630.88 Mn
Sep 30, 2025 467.84 Mn
Jun 30, 2025 345.33 Mn
Mar 31, 2025 280.42 Mn
Dec 31, 2024 237.08 Mn
Sep 30, 2024 293.37 Mn
Jun 30, 2024 332.87 Mn
Mar 31, 2024 299.44 Mn
Dec 31, 2023 264.60 Mn
Sep 30, 2023 284.39 Mn
Jun 30, 2023 298.83 Mn
Mar 31, 2023 210.44 Mn